An observational study in Near-Infrared Spectroscopy, Volleyball and Prefrontal Cortex, sponsored by Istinye University. Not yet recruiting. Open to female participants aged 17 Years to 21 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Istinye University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
34 volunteer professional female volleyball players (aged 17-21), licensed in the Turkish Volleyball Federation (TVF) Women's Volleyball League 2 and 3, will be included in the study. No intervention will be applied. All participants will be assessed in a single session, in which cortical oxygenation of the prefrontal, premotor and motor cortex will be measured with a wireless fNIRS device and serve speed will be measured with a radar gun simultaneously during the volleyball serve.
34 professional female volleyball players licensed in the TVF Women's Volleyball League 2 and League 3, aged 17-21 years, with at least three years of regular training and competition experience, will be included using purposive sampling. Sample size was determined using G*Power 3.1 software (correlation: point biserial model, one-tailed) with 80% power, 0.05 type-1 error and an effect size of 0.40, giving a minimum of 34 participants. All participants will be assessed in a single session at the Istinye University Physiotherapy and Rehabilitation Application and Research Center (ISUFIZYOTEM). After a standardized 15-minute warm-up and placement of the fNIRS headset, each participant will perform five successful serves with 60 seconds of rest between serves, using the serve type they use most often in competition. Cortical oxygenation and serve speed will be recorded simultaneously for each serve. Measurements will be scheduled at least 24 hours after the last official match or high-intensity training session. Primary assessments include changes in oxyhemoglobin and deoxyhemoglobin in the prefrontal, premotor and motor cortex during the serve, measured with a wireless fNIRS device; serve speed, defined as the highest speed (km/h) of five successful serves and measured with a Bushnell Velocity Speed Gun radar; and demographic and anthropometric data, including age, height, body weight, body mass index, years of training, weekly training frequency, playing position and serve type.
Istinye University is the lead sponsor of 224 studies on the registry; 96 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Female volleyball players aged 17-21 years who hold an active license with Unsped Culture and Sports Club and compete in the Turkish Volleyball Federation (TVF) Women's 2nd and 3rd Leagues. Participants play as setter, outside hitter, opposite or middle blocker (liberos are excluded because they do not serve) and have at least three years of regular volleyball training and official competition experience. Players with musculoskeletal surgery in the last six months, current pain or acute injury affecting serving, or a neurological, vestibular, cognitive, cardiovascular, respiratory or metabolic condition limiting physical activity are excluded. Participants are recruited through the club and assessed in a single session at the Istinye University Physiotherapy and Rehabilitation Application and Research Center (ISUFIZYOTEM).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
In this study, the primary aim is to examine the correlation between serve speed and cortical oxygenation. The secondary aim is to examine differences in serve speed and cortical oxygenation between playing positions. Therefore, no separate groups are defined; all participants are analyzed as a single sample. No intervention is applied.
Cortical Oxygenation Measured by Functional Near-Infrared Spectroscopy
Changes in oxyhemoglobin and deoxyhemoglobin concentrations in the prefrontal, premotor and motor cortex during the volleyball serve will be measured with a wireless functional near-infrared spectroscopy (fNIRS) device. fNIRS is a non-invasive, portable neuroimaging method that indirectly assesses neural activation by measuring hemodynamic changes in the cortex through optical sensors placed on the head. The sensors will be positioned over the prefrontal, premotor and motor cortex, and cortical oxygenation changes will be recorded in real time. Each task will be repeated three times to ensure intra-subject reliability, and sensor signals will be checked after each repetition, with calibration performed if necessary.
Time frame: Baseline
Serve speed
Serve speed (km/h) will be measured with a Bushnell 1101911 Velocity Speed Gun radar. The device will be placed on a fixed tripod 5 meters from the net, parallel to the service line, and focused on the line where the ball passes at a height of approximately 1.5 meters, ensuring correct intersection of the radar beam with the ball. Each participant will perform five successful serves in accordance with competition rules, with a serve considered successful if the ball crosses the net and lands within the court. Sixty seconds of rest will be given between serves, and device calibration will be checked after each serve to minimize measurement errors. The highest recorded serve speed for each participant will be used as the performance indicator. All measurements will be performed under similar temperature and humidity conditions.
Time frame: Baseline
No study locations are listed for this record.
Plan to share: Undecided
Start is estimated for Nov 2026; primary completion for Dec 2026, 1 month later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.